Phosphine-Built-in Porous Organic Cage for Stabilization and Boosting the Catalytic Performance of Palladium Nanoparticles in Cross-Coupling of Aryl Halides

Herein, we report first a novel phosphine-containing porous organic cage (PPOC) from a [2 + 3] self-assembly of triphenyl phosphine-based trialdehyde and (S,S)-1,2-diaminocyclohexane via dynamic imine chemistry, which was employed as a porous material for the controlled growth of palladium nanoparticles (NPs) due to the strong affinity of Pd to the phosphine ligand based on the principle of hard and soft acids and bases. Comprehensive characterizations including X-ray diffraction, transmission electron microscopy, X-ray photoelectron spectroscopy, NMR, and X-ray absorption spectroscopy reveal that ultrafine Pd NPs with narrow size distribution (1.7 ± 0.3 nm) and enhanced surface electronic density via a strong interaction between NPs and phosphine were homogeneously dispersed in the PPOC. The resultant catalyst Pd@PPOC exhibits remarkably superior catalytic activities for various cross-coupling reactions of aryl halides, for example, Sonogashira, Suzuki, Heck, and carbonylation. The catalytic activity of Pd@PPOC outperforms the state-of-the-art Pd complexes and other Pd NPs supported on N-containing porous cages under identical conditions, owing to the enhanced surface electronic density of Pd NPs and their high stability and dispersibility in solution. More importantly, Pd@PPOC is highly stable and easily recycled and reused without loss of their catalytic activity. This work provides a new functional POC with extended potentials in catalysis and material science.

Supported Palladium Nanoparticles that Catalyze Aminocarbonylation of Aryl Halides with Amines using Oxalic Acid as a Sustainable CO Source

Polystyrene-supported palladium (Pd@PS) nanoparticles (NPs) have been used to catalyze the aminocarbonylation of aryl halides with amines using oxalic acid as a CO source for the first-time for the synthesis of amides. Furthermore, o-iodoacetophenones participated in amidation and cyclization reactions to give isoindolinones in a single step following a concerted approach. Oxalic acid has been used as a safe, environmentally benign and operationally simple ex situ sustainable CO source under double-layer-vial (DLV) system for different aminocarbonylation reactions. Catalyst stability under a CO environment is a challenging task, however, Pd@PS was found to be recyclable and applicable for a vast substrate scope avoiding regeneration steps. Easy handling of oxalic acid, additive and base-free CO generation, catalyst stability and effortless catalyst separation from the reaction mixture by filtration and introduce of DLV are the added advantages to make the overall process a sustainable approach.

Supported palladium nanoparticles-catalyzed decarboxylative coupling approaches to aryl alkynes, indoles and pyrrolines synthesis

The polystyrene supported palladium (Pd@PS) nanoparticles catalyzed decarboxylative coupling of arylhalides and alkynyl carboxylic acids was developed for the synthesis of diaryl alkynes, indoles and pyrrolines.

Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis

Leukocytes play a major role in the development and progression of autoimmune diseases. We measured gene expression differences in leukocytes from patients that were antineutrophil cytoplasmic autoantibody (ANCA) positive, patients with systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA), and healthy donors to explore potential pathways for clinical intervention. Leukocyte gene expression profiles were determined on Affymetrix U133A/B chips in 88 autoimmune patients, 28 healthy donors, and healthy donor leukocyte cell subtypes that were activated in vitro. Comparison of gene expression in leukocytes identified differentially expressed signature genes that distinguish each donor source. The microarray expression levels for many signature genes correlated with the clinical activity of small vessel vasculitis in the ANCA patients; a result confirmed by quantitative real time-polymerase chain reaction for 16 relevant genes. Comparison with in vitro-activated leukocyte subtypes from healthy donors revealed that the ANCA signature genes were expressed by neutrophils while the SLE signature genes were expressed in activated monocytes and T cells. We have found that leukocyte gene expression data can differentiate patients with RA, SLE, and ANCA-related small vessel vasculitis. Monitoring changes in the expression of specific genes may be a tool to help quantify disease activity during treatment.